MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA

Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Fuso Pharmaceutical Industries, Ltd. engages in the manufacture and sale of ethical pharmaceutical and medical equipment. It operates through the Pharmaceuticals and Real Estate divisions. The Pharmaceuticals division deals with the manufacture and sale of pharmaceutical products which mainly focus on prescription drugs, infusions, and artificial kidney dialysis solutions. The Real Estate division handles leasing of real estate properties. The company was founded on March 25, 1937 and is headquartered in Osaka, Japan.

Rescue Hearing aims to develop technology that helps in the field of hearing loss treatment and prevention.

Beijing Henghua Yongli Electric Power Engineering Co., Ltd., established on 2016-04-14, Business scope includes construction general contracting;engineering design;Professional contractors;Labor subcontracting;Sales of machinery and equipment,building materials,hardware,automobile parts,household items,household appliances,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),decorative material;technology development,transfer,consult,Serve;Import and export;Agent import and export;Technology Import and Export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

deCODE genetics, Inc. (Icelandic: Íslensk erfðagreining) is a biopharmaceutical company based in Reykjavík, Iceland. The company was founded in 1996 by Kári Stefánsson to identify human genes associated with common diseases using population studies, and apply the knowledge gained to guide the development of candidate drugs. The company isolated genes believed to be involved in cardiovascular disease, cancer and schizophrenia, among other diseases (the company's research concerning the latter is said to represent the first time a gene has been identified by two independent studies to be associated with schizophrenia).

KeyGene NV provides its partners and customers in the plant breeding industry contract research, partnerships and molecular genetic services. It delivers novel enabling technologies and applications to support companies and institutes that carry out fundamental or applied genetic genomic research and that seek to enhance the quality of their products through the improvement of their genetic material. The company was established in 1989 and is headquartered in Wageningen, the Netherlands.

Kineta Two LLC operates as a biotechnology company. It develops antiviral programs. The company is headquartered in Seattle, WA.

Shanghai Yuanqing Biotechnology Co., Ltd., established on 2018-08-31, Business scope includes engaging in biotechnology,Technology development in the field of computer software technology,Technical Services,technical consulting,technology transfer;medical instruments,Sales of computers and their accessories;General machinery and equipment rental;Business Consulting;Engaged in the import and export of goods and technology;medicine,Internet Information Service for Medical Devices. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Toyo Kohan Co., Ltd. engages in the manufacture and sale of of tinplate, sheet metals, and different types of surface-treated steel sheets as well as a variety of functional materials. It operates through the following segments: Steel Sheet, Functional Materials, and Machinery. The Steel Sheet segment offers functional films for containers, steel plates, and processed steel sheets used as material for electrical and electronic parts, for vehicles, and for external cladding and construction. The Functional Material segment deals with aluminum substrate for magnetic disks and optical functional films. The Machinery segment handles automotive press die and other kinds of die, steel strip for packing materials, machinery instruments, and hard alloys. The company was founded on April 11, 1934 and is headquartered in Tokyo, Japan.

Cotinga Pharmaceuticals, Inc. is engaged in the development of therapeutics for the treatment of cancer and other unmet medical needs. It offers COTI-2 and COTI-219 pipelines. The COTI-2 pipeline targets gynecologic cancers and head and neck squamous cell carcinoma. The COTI-219 pipeline focuses on the treatment of lung, colorectal, pancreatic and thyroid cancers. The company was founded on October 13, 2006 and is headquartered in Toronto, Canada.

Elitra Pharmaceuticals, Inc. used to develop pharmaceutical products. The company employed proprietary methods for gene analysis and anti-microbial drug discovery. It used to develop technology to miniaturize anti-microbial drug screens. It was also engaged in the identification, development and commercialization of novel antimicrobial compounds that target essential gene products of pathogenic organisms. The company was founded in 1997 and was headquartered in San Diego, CA

Genematrix is developing new diagnostic products for various diseases by developing a globally competitive core platform technologies in the field of molecular diagnostics, which is attracting attention as a high-technology in the line of biotechnology. The Molecular Diagnostic market has high growth rates among in-vitro diagnostics markets and is a high value-added industry that is highly dependent on advanced countries since global companies prevailed the most core technologies. Genematrix, since the beginning of the company, has developed its own technologies that is globally competitive in the field of molecular diagnostics through joint research with domestic and international companies and research institutes.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France.